Antimycobacterial compounds. New pyrrole derivatives of BM212
- 1 March 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (6) , 1453-1458
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212Bioorganic & Medicinal Chemistry, 2003
- Active Tuberculosis in Individuals Infected with Human Immunodeficiency Virus after Isoniazid ProphylaxisClinical Infectious Diseases, 2000
- Building a pharmacophore model for a novel class of antitubercular compoundsIl Farmaco, 2000
- New pyrrole derivatives as antimycobacterial agents analogs of BM212Bioorganic & Medicinal Chemistry Letters, 1999
- Recent developments in epidemiology, treatment, and diagnosis of tuberculosisCurrent Infectious Disease Reports, 1999
- Bactericidal Activities of the Pyrrole Derivative BM212 against Multidrug-Resistant and Intramacrophagic Mycobacterium tuberculosis StrainsAntimicrobial Agents and Chemotherapy, 1998
- 1,2-Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase-2Journal of Medicinal Chemistry, 1997
- Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial ActivityJournal of Medicinal Chemistry, 1996
- Analysis of Conformational Coverage. 1. Validation and Estimation of CoverageJournal of Chemical Information and Computer Sciences, 1995
- Poling: Promoting conformational variationJournal of Computational Chemistry, 1995